Metastatic Lung Adenocarcinoma Treatment Market Size Worth USD 14.17 billion by 2034 | CAGR: 11.2%

The Metastatic Lung Adenocarcinoma Treatment Market Share size & share value expected to touch USD 14.17 billion by 2034, to grow at a CAGR of 11.2% during the forecast period.

预计到2034年，转移性肺腺癌治疗市场规模及份额将达到1417亿美元，预计在预测期内将以11.2%的复合年增长率增长。